Ovarian cancer ascites protects from TRAIL-induced cell death through αvβ5 integrin-mediated focal adhesion kinase and Akt activation
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/onc2010107.pdf
Reference43 articles.
1. Abendstein B, Stadimann S, Knabbe C, Buck M, Muller-Holzner E, Zeimet AG et al. (2000). Regulation of transforming growth factor-beta secretion by human peritoneal mesothelial and ovarian carcinoma cells. Cytokine 12: 1115–1119.
2. Alper O, Bergmann-Leitner ES, Bennett TA, Hacker NF, Stromberg K, Stetler-Stevenson WG . (2001). Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells. J Natl Cancer Inst 93: 1375–1384.
3. Carreiras F, Rigot V, Cruet S, Andre F, Gauduchon P, Marvaldi J . (1999). Migration properties of the human ovarian adenocarcinoma cell line IGROV1: importance of alpha(v)beta3 integrins and vitronectin. Int J Cancer 80: 285–294.
4. Contos JJ, Ishii I, Chun J . (2000). Lysophosphatidic acid receptors. Mol Pharmacol 58: 1188–1196.
5. Cruet-Hennequart S, Maubant S, Luis J, Gauduchon P, Staedel C, Dedhar S . (2003). Alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells. Oncogene 22: 1688–1702.
Cited by 80 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ascites microenvironment conditions the peritoneal pre-metastatic niche to promote the implantation of ovarian tumor spheroids: Involvement of fibrinogen/fibrin and αV and α5β1 integrins;Experimental Cell Research;2024-08
2. Therapy-induced secretion of spliceosomal components mediates pro-survival crosstalk between ovarian cancer cells;Nature Communications;2024-06-19
3. Application of LMLC Prognostic Score in Survival Predicting of Malignant Pleural Effusion Secondary to Pleural Mesothelioma;2024-05-14
4. A novel class of inhibitors that disrupts the stability of integrin heterodimers identified by CRISPR-tiling-instructed genetic screens;Nature Structural & Molecular Biology;2024-02-05
5. Progress in the treatment of malignant ascites;Critical Reviews in Oncology/Hematology;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3